Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Levitee Labs Inc (LVTTF)

Levitee Labs Inc (LVTTF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0020 +35.00%
on 11/07/23
0.0027 unch
on 11/13/23
+0.0007 (+35.00%)
since 10/10/23
3-Month
0.0018 +50.00%
on 08/17/23
0.0058 -53.45%
on 09/28/23
-0.0158 (-85.41%)
since 08/08/23
52-Week
0.0011 +145.45%
on 02/22/23
0.0350 -92.29%
on 06/01/23
-0.0050 (-64.94%)
since 11/11/22

Most Recent Stories

More News
Levitee Labs Announces Philip Van Den Berg to Join as Interim CEO and the Board of Directors and Close First Tranche of Private Placement for $1.5 Million

VANCOUVER, British Columbia, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7) (the "Company" or "Levitee”) is...

OTC.VN : 0.330 (+3.13%)
LVT.CN : 0.005 (unch)
LVTTF : 0.0027 (+35.00%)
Levitee Labs Announces Non-Brokered Private Placement of up to $3,000,000

Offering is priced at $0.20 per offered unit, with a full warrant at $0.40 for 24 monthsProceeds to be used for organic and inorganic growth initiatives...

OTC.VN : 0.330 (+3.13%)
LVT.CN : 0.005 (unch)
LVTTF : 0.0027 (+35.00%)
Levitee Labs Signs Retail Distribution Agreement with Body Energy Club for MONKE Nutraceuticals

In business for 20 years, Body Energy Club is the leading health supplement and vitamin retailer in Western Canada, with additional locations established...

OTC.VN : 0.330 (+3.13%)
LVT.CN : 0.005 (unch)
LVTTF : 0.0027 (+35.00%)
Levitee Labs Partners with Canntab Therapeutics to Provide Alternatives to Opioids

The agreement is anticipated to contribute to correcting the opioid crisis in Canada and serve as a foundation for both companies to potentially expand...

OTC.VN : 0.330 (+3.13%)
LVT.CN : 0.005 (unch)
LVTTF : 0.0027 (+35.00%)
CTABF : 0.0001 (unch)
CORRECTION - Levitee Labs Announces Medical Advisory Board

VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- In a press release issued earlier today under the same headline by Levitee Labs Inc. (CSE:...

OTC.VN : 0.330 (+3.13%)
LVT.CN : 0.005 (unch)
LVTTF : 0.0027 (+35.00%)
Levitee Labs Announces Medical Advisory Board

Newly appointed Medical Advisory Board brings decades of relevant experience in addiction, mental health, drug development, compounding, chronic pain,...

OTC.VN : 0.330 (+3.13%)
LVT.CN : 0.005 (unch)
LVTTF : 0.0027 (+35.00%)
Levitee Labs Announces Strategic Partnership with LiveRx Research Group to Provide Equitable Access to Hepatitis C Care throughout Alberta, Canada

Treatment for Hepatitis C Virus (HCV) is effective in over 95% of infected patients, yet remains disproportionately unavailable to certain patient groups...

OTC.VN : 0.330 (+3.13%)
LVT.CN : 0.005 (unch)
LVTTF : 0.0027 (+35.00%)
Levitee Labs Appoints Noha ElSayed as Executive Director for Levitee Clinics and Levitee Pharmacies in the Alberta Region

Levitee adds Noha ElSayed, an expert in compounding and pharmacy operations, to the Levitee Clinics and Levitee Pharmacies management teamMrs. ElSayed has...

OTC.VN : 0.330 (+3.13%)
LVT.CN : 0.005 (unch)
LVTTF : 0.0027 (+35.00%)
Levitee Labs Signs Letter of Intent to Acquire a Chain of Specialty Addiction Pharmacies Located in British Columbia

Signed LOI to acquire 100% interest in chain of specialty addiction pharmacies in Vancouver, BCAcquisition price of $4.0 million based upon approximately...

OTC.VN : 0.330 (+3.13%)
LVT.CN : 0.005 (unch)
LVTTF : 0.0027 (+35.00%)
Levitee Labs Publishes First Combined Revenue Figures for September 2021 and October 2021

Levitee Labs achieves combined September 2021 and October 2021 revenues of $1,553,728Consistent revenue growth and acquisitions across core divisions of...

OTC.VN : 0.330 (+3.13%)
LVT.CN : 0.005 (unch)
LVTTF : 0.0027 (+35.00%)

Key Turning Points

3rd Resistance Point 0.0027
2nd Resistance Point 0.0027
1st Resistance Point 0.0027
Last Price 0.0027
1st Support Level 0.0027
2nd Support Level 0.0027
3rd Support Level 0.0027

See More

52-Week High 0.0350
Fibonacci 61.8% 0.0221
Fibonacci 50% 0.0181
Fibonacci 38.2% 0.0140
Last Price 0.0027
52-Week Low 0.0011

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar